Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery
Status:
Terminated
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This study hopes to determine the optimal antifibrinolytic dosing to decrease bleeding and
blood transfusion after cardiac surgery without increasing adverse events